BARDA CBRN Medical Countermeasure Portfolio
BARDA Chemical, Biological, Radiological, and Nuclear medical countermeasure portfolio data. The public JSON feed currently contains 134 portfolio products. CBRN branches represented include Antimicrobials, Antivirals & Antitoxins, Burn & Blast, Chemical, Other, Rad/Nuc, Vaccines. Impact areas represented include Combination Product, Devices, Enabling Technologies, Other, Therapeutics, Vaccines.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | Dataset |
|---|---|
| accessRights | public |
| contactPoint |
[ { "fn": "BDR Administrative Inbox", "@type": "Kind", "hasEmail": "mailto:BDR_Admin_Inbox@hhs.gov" } ] |
| description | BARDA Chemical, Biological, Radiological, and Nuclear medical countermeasure portfolio data. The public JSON feed currently contains 134 portfolio products. CBRN branches represented include Antimicrobials, Antivirals & Antitoxins, Burn & Blast, Chemical, Other, Rad/Nuc, Vaccines. Impact areas represented include Combination Product, Devices, Enabling Technologies, Other, Therapeutics, Vaccines. |
| distribution |
[ { "@type": "Distribution", "title": "BARDA CBRN Medical Countermeasure Portfolio JSON Data", "format": "JSON", "mediaType": "application/json", "description": "Public JSON data feed backing the MedicalCountermeasures.gov page.", "downloadURL": "https://medicalcountermeasures.gov/app/cbrn/getdata", "accessRestriction": [ { "@type": "AccessRestriction", "restrictionStatus": "Unrestricted" } ] } ] |
| identifier | https://medicalcountermeasures.gov/barda/cbrn#portfolio |
| inventoried | 2026-09-27 |
| keyword |
[ "361 Product (HCT/P)", "AMR Bacteria", "ASPR", "Anthrax", "Antimicrobials", "Antivirals & Antitoxins", "Approved", "BARDA", "Botulism", "Burn & Blast", "CBRN", "COVID-19", "Chemical", "Cleared", "Combination Product", "Devices", "Enabling Technologies", "Filoviruses", "Fungi", "Licensed", "MedicalCountermeasures.gov", "Nuclear Detonation", "Other", "Phase 1", "Phase 1/2", "Phase 2", "Phase 2/3", "Phase 3", "Pre-clinical", "Project BioShield", "Rad/Nuc", "Radiological", "Smallpox", "Therapeutic Platforms", "Therapeutics", "Vaccines", "biological threats", "chemical threats", "medical countermeasures", "nuclear threats", "portfolio", "public health emergencies", "radiological threats" ] |
| landingPage | {'@type': 'Document', 'title': 'BARDA CBRN Medical Countermeasure Portfolio', 'accessURL': 'https://medicalcountermeasures.gov/barda/cbrn#portfolio'} |
| modified | 2026-06-18 |
| publisher |
{ "name": "Biomedical Advanced Research and Development Authority (BARDA)", "@type": "Organization", "subOrganizationOf": [ { "name": "Administration for Strategic Preparedness and Response (ASPR)", "@type": "Organization", "subOrganizationOf": [ { "name": "U.S. Department of Health and Human Services", "@type": "Organization" } ] } ] } |
| theme |
[ { "@type": "Concept", "prefLabel": "Health; Emergency Preparedness; Medical Countermeasures" } ] |
| title | BARDA CBRN Medical Countermeasure Portfolio |
